DUBLIN (AP) _ Amarin Corp. PLC (AMRN) on Thursday reported a loss of $1.6 million in its first quarter.

On a per-share basis, the Dublin-based company said it had a loss of less than 1 cent. Earnings, adjusted for stock option expense, were 3 cents per share.

The biopharmaceutical company posted revenue of $142.2 million in the period, missing Street forecasts. Six analysts surveyed by Zacks expected $146.8 million.

Amarin shares have risen 6% since the beginning of the year. The stock has decreased 34% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News